Point-of-Care Diagnostics & Global Health World Congress

Home
|
Posters
|

Symposium
Training Courses

|
Media
|

Keynote Speakers

Yolanda Cillo Medical Director, Abbott Diagnostics	Gene Dantsker Director, Business Development and Licensing, Qualcomm LIFE, Inc.	Marc Madou Chancellor's Professor, University of California-Irvine	John McDevitt Chair, Department Biomaterials, New York University College of Dentistry Bioengineering Institute	Arben Merkoçi ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Català de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST)	Sergey Shevkoplyas Associate Professor, Biomedical Engineering, University of Houston
Bernhard Weigl Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund	David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles	Alan Wright Chief Medical Officer, Roche Diagnostics Corporation

Overview

Bringing together the key opinion leaders from both academia and industry, this conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.

This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.

Registered conference delegates have access to the additional co-located parallel conferences:

1. Lab-on-a-Chip, Microfluidics & Microarray World Congress
2. Next-Generation Sequencing (NGS), Single Cell Analysis (SCA) and Mass Spectrometry: The Road to Diagnostics

This provides conference delegates the ability to Mix-and-Match Tracks, Topics, and Presentations as well as Maximizing Networking Opportunities. The Exhibit Hall is Co-Located with the Conference Tracks in the Conference Center for Excellent Networking Opportunities and a Large Number of Leading-Edge Companies from Around the World will be Displaying their Technologies, Products and Services.  Excellent opportunity for business development, partnering, and sales venue for vendors in these fields. Exhibit Hall is Open all day on September 29 and 30, 2015.

Submit a Poster to Present your Research at this Conference. Poster Submission Deadline: September 22, 2015.

Agenda Topics

Emerging Technologies and Emerging Companies Showcase
POC in Cancer and Oncology Testing
POC in Cardiovascular Disease Testing
POC in Global Health -- A Worldwide Perspective
POC in Infectious Disease Testing
Point-of-Care (POC) Diagnostics for Infectious Disease Applications
The Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications

Low-Cost POC Devices for Deployment Worldwide
Paper-based Microfluidics
Sensors for Deployment in POC Settings

Using Microfluidics to Capture and Interrogate Various Analyte Classes for POC Testing
Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing for Global Health

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Wilbur Lam, Assistant Professor, Georgia Institute Of Technology
Barbara Smith, Assistant Professor, School of Biological and Health Systems Engineering, Arizona State University
Dong-Ku Kang, Assistant Research Scientist, University of California-Irvine
James Herron, Associate Professor, University Of Utah
Jane Brock, Chief of Breast Pathology, Brigham and Women’s Hospital, Harvard Medical School
Holger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH
Alexander Asanov, Chief Scientific Officer, TIRF Labs, Inc.
Hariharan Subramanian, Chief Technology Officer, NanoCytomics LLC
Paul Drain, Instructor of Medicine, Harvard Medical School
James Boiani, Partner, Epstein Becker & Green, P.C.
Claude Dufresne, President, SCIENION US INC
Marya Lieberman, Professor, University of Notre Dame
Xianqiang Mi, Professor, Shanghai Advanced Research Institute Chinese Academy of Sciences
Haim Bau, Professor, University Of Pennsylvania
Yu-Hwa Lo, Professor, University of California San Diego
Utkan Demirci, Professor, Stanford University School of Medicine
David Issadore, Professor, University of Pennsylvania
Dean Ho, Professor and Co-Director, University of California-Los Angeles
John Brennan, Professor and Director, Biointerfaces Institute, McMaster University
Rashid Bashir, Professor And Head, University Of Illinois
Jason Heikenfeld, Professor and VP Operations, UC Office of Innovation, University of Cincinnati
Changchun Liu, Research Associate Professor, University of Pennsylvania
Teodor Veres, Section Head, Bioanalytical Micro-Nano Devices, Life Sciences Division, National Research Council of Canada & McGill University
Lingjun Chen, Vice President, Roche Molecular Systems Inc

Corporate Sponsors	Web Sponsors	Offical Journal Partner	Networking